HydroCision

HydroCision is a commercial-stage medical device company leveraging its core FluidJet technology to create precise, tissue-differentiating surgical instruments for minimally invasive procedures. The company has launched products targeting orthopedic and spine surgery, including TenJet for tendinosis treatment and SpineJet for disc material removal, aiming to improve clinical and economic outcomes. As a private company, it is led by an experienced management team and board, focusing on expanding the application of its platform technology into new surgical specialties. Its value proposition centers on a non-thermal, precise cutting mechanism that differentiates tissue types and simultaneously removes debris.

Proprietary FluidJet technology that delivers a high-velocity, non-thermal stream of sterile saline to selectively cut and simultaneously aspirate soft tissue in a minimally invasive manner.

In spine discectomy, HydroCision competes with mechanical shavers, lasers, and radiofrequency probes from giants like Medtronic and Stryker. In percutaneous tenotomy, it competes with simple needle fenestration procedures, other mechanical debridement devices, and biologic injections. Its key differentiation is its non-thermal, tissue-selective cutting with integrated aspiration, which it must prove offers superior clinical and economic outcomes.